Orbiscan and Diagnostics Private Limited
About Orbiscan and Diagnostics Private Limited
Data last updated:
Orbiscan and Diagnostics Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 29 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC318373.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Yogesh Kumar and Shweta Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wz – 52A J Block Ground Floor Beriwala Bagh, New Delhi, Delhi, India – 110064.
As per the financials filed for FY 2025, the company reported a revenue of ₹97.35 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.02 Lakh (net margin 1%) and EBITDA of ₹5.07 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 14% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Orbiscan and Diagnostics Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressWz – 52A J Block Ground Floor Beriwala Bagh, New Delhi, Delhi, India – 110064
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Orbiscan and Diagnostics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Orbiscan and Diagnostics is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Orbiscan and Diagnostics Private Limited, buy the company report.
Financials of Orbiscan and Diagnostics Private Limited
FY 2025 filings availableOrbiscan and Diagnostics Private Limited reported revenue of ₹97.35 Lakh (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 11% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Orbiscan and Diagnostics Private Limited, buy the company report.
Board of directors of Orbiscan and Diagnostics Private Limited
Orbiscan and Diagnostics has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yogesh Kumar | Director | 21 Apr 2023 | 3 Years 6 Months | Current |
| Shweta Agarwal | Director | 29 May 2017 | 9 Years 4 Months | Current |
Peer comparison
Orbiscan and Diagnostics Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Plasmacare Diagnostics Private Limited | ₹98.19 Lakh (FY 2025) | 18.0% | Ahmedabad, Gujarat, India | |||
| Neocare Diagnostics Private Limited | ₹98.11 Lakh (FY 2024) | 12.0% | Mumbai, Maharashtra, India | |||
| Orbiscan and Diagnostics Private Limitedthis company | ₹97.35 Lakh (FY 2025) | ₹1.02 Lakh | 1% | 11.0% | New Delhi, Delhi, India | |
| Samyak Daignostic Private Limited | ₹97.29 Lakh (FY 2025) | 1.0% | Mumbai, Maharashtra, India | |||
| Agility Diagnostics Private Limited | ₹96.7 Lakh (FY 2025) | 87.0% | Gurugram, Haryana, India |
To see the full peer comparison of Orbiscan and Diagnostics Private Limited, buy the company report.
Auditor
Orbiscan and Diagnostics Private Limited is audited by M P GUPTA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M P GUPTA & ASSOCIATES | FY 2020 | 027523N |
Shareholding
The shareholding of Orbiscan and Diagnostics Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Orbiscan and Diagnostics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Orbiscan and Diagnostics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orbiscan and Diagnostics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Orbiscan and Diagnostics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Orbiscan and Diagnostics Private Limited has 6 board changes on record since 2017: 2 appointments and 4 cessations. The latest: Yogesh Kumar ceased to be Additional Director on 29 Sep 2023.
Frequently asked questions
Orbiscan and Diagnostics is an active private limited company based in New Delhi, Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 29 May 2017 (9+ years old) and is registered under CIN U74999DL2017PTC318373.
Orbiscan and Diagnostics has 2 current directors:
- Yogesh Kumar - Director
- Shweta Agarwal - Director
The latest financial statements of Orbiscan and Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Orbiscan and Diagnostics is U74999DL2017PTC318373. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orbiscan and Diagnostics was incorporated on 29 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Orbiscan and Diagnostics by revenue are Plasmacare Diagnostics Private Limited, Neocare Diagnostics Private Limited, Samyak Daignostic Private Limited, Agility Diagnostics Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).
Yogesh Kumar ceased to be Additional Director on 29 Sep 2023. Kuldip Singh ceased to be Director on 21 Apr 2023. Yogesh Kumar was appointed as Director on 21 Apr 2023. Orbiscan and Diagnostics has 6 board changes on record in total.
The registered office of Orbiscan and Diagnostics is at Wz – 52A J Block Ground Floor Beriwala Bagh, New Delhi, Delhi, India – 110064.
Orbiscan and Diagnostics operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
The compliance status of Orbiscan and Diagnostics is compliant as of 18 September 2026. The company is actively filing with the Registrar of Companies.
Orbiscan and Diagnostics can be reached at its registered office: Wz – 52A J Block Ground Floor Beriwala Bagh, New Delhi, Delhi, India – 110064.